GLP-1 Medications in India 2026: Ozempic, Rybelsus, and Costs

GLP-1 in India: Ozempic, Rybelsus, Wegovy and Mounjaro availability, generic semaglutide, what drives cost, insurance, and getting a prescription.

Regimen Team · · 7 min read

If you’re managing type 2 diabetes in India, you’ve probably already heard of Ozempic. If you’re exploring it for weight management, the picture is evolving fast: Indian pharmaceutical companies are entering this space, and costs are going to come down. Here’s where things stand in 2026 and what’s actually accessible right now.

What’s Available in India

India has one of the world’s largest type 2 diabetes populations (over 100 million people). GLP-1 awareness has grown rapidly as a result, and the prescriber network is well ahead of where it was two or three years ago.

MedicationActive ingredientIndicationAvailable in IndiaPrice
Ozempic (injectable)SemaglutideT2DMYes (launched December 2025, according to press reports)Check current MRP
Rybelsus (oral)SemaglutideT2DMYesCheck current MRP
VictozaLiraglutideT2DMYesCheck current MRP
MounjaroTirzepatideT2DM and weight managementYes (launched March 2025, according to press reports)Check current MRP
WegovySemaglutide 2.4mgWeight managementYes (launched June 2025, according to press reports)Check current MRP

We could not verify a current official price list for these products (CDSCO and NPPA were not reachable when we checked in November 2026), so we have not listed prices. The MRP printed on the pack, including taxes, is the legal maximum retail price; according to press reports, Novo Nordisk cut Ozempic and Wegovy prices in India in 2026 after generic semaglutide launched.

Costs are significantly lower than the US or Europe, but still significant relative to Indian incomes. This is exactly where the Indian generic and biosimilar story matters.

On Ozempic? Regimen’s Ozempic app logs the shot in one tap, reminds you before the next one, and ties your side effects and weight to each dose step.

The Indian Pharma Angle: Why This Market Is Different

India’s pharmaceutical manufacturing ecosystem is the most important context for understanding GLP-1 access here.

According to press reports, the semaglutide patent in India expired in March 2026 and Indian manufacturers have since launched generic semaglutide. Biocon in particular has biosimilar expertise (they produce widely used biosimilar insulins). Tirzepatide (tirz) remains a branded product. As more generic semaglutide products reach pharmacies, the monthly cost picture for GLP-1 medications in India is changing.

This is India-specific: the biosimilar pathway that makes GLP-1 costs prohibitive in most other markets is being actively solved by domestic Indian pharma.

Pro Tip

If cost is your primary concern with GLP-1 medications right now, ask your endocrinologist specifically about Indian-manufactured options. According to press reports, generic semaglutide products from domestic manufacturers have been launching since March 2026. Novo Nordisk’s branded pricing is not the only option in India the way it is in most other countries.

Rybelsus: India’s Most Overlooked GLP-1 Option

Rybelsus (oral semaglutide) deserves specific attention for the Indian market. India has a significant proportion of patients who are hesitant about self-injection, particularly for weekly GLP-1 injections. Rybelsus is Novo Nordisk’s oral semaglutide and offers the same active ingredient as Ozempic without the injection.

It’s approved for T2DM. It’s available at major pharmacies in India.

If you’re managing T2DM and want a GLP-1 option without weekly injections, Rybelsus is the direct answer.

Warning

Rybelsus requires specific administration to work: take it on an empty stomach with no more than 4oz (120mL) of water, at least 30 minutes before your first food or drink of the day, and before any other medications. The absorption is highly sensitive to this protocol. Many patients don’t see the full benefit because they don’t follow the administration instructions precisely.

Public System Coverage and Insurance: The Realistic Picture

Public health system coverage

India does not have a universal public drug coverage system in the way the UK (NHS) or France (CPAM) does. GLP-1 medications are not covered under standard government health schemes for most patients.

Private health insurance

Most Indian health insurance policies cover T2DM medications, but coverage for GLP-1 specifically varies by policy. Some corporate health plans include expanded metabolic health benefits. Check your specific policy’s terms.

For weight management (without T2DM): coverage is very limited in the Indian insurance market as of 2026. Out-of-pocket cost is the realistic assumption.

How to Get a GLP-1 Prescription in India

Any registered physician can prescribe GLP-1 medications in India. In practice, the prescribers managing these protocols most effectively are:

  • Endocrinologists and diabetologists at major private hospital chains (Apollo, Fortis, Manipal, Max Healthcare, Medanta)
  • General physicians at large multi-specialty hospitals in metro areas
  • Telehealth platforms (Practo, mfine, and similar) for initial consultations and prescription renewals

The process:

  1. Book with an endocrinologist or diabetologist. At Apollo or Fortis, you can do this online through their app.
  2. Bring your recent HbA1c, fasting glucose, BMI, and any cardiovascular history. This is what the prescriber needs.
  3. If you’re a T2DM patient meeting criteria, Ozempic or Rybelsus is a mainstream prescribing option. The conversation is not unusual.
  4. For weight management without T2DM: Wegovy and Mounjaro are the products launched in India for weight management (according to press reports); Ozempic for weight loss would be off-label. Be transparent about your goals.
  5. Fill at a major pharmacy or hospital pharmacy. For branded Ozempic, hospital pharmacies in metro cities have the most reliable stock.

Use the GLP-1 Dose Calculator to map out your titration schedule from starting dose to maintenance.

For TRT access in India, see the India TRT Guide.

Tracking Your Protocol

Weekly GLP-1 injections (or daily Rybelsus) involve titration schedules that run for months. Tracking weight, dose tier, and side effects throughout the titration gives you a clear record for provider visits and helps you identify when a dose change is driving a response.

Regimen supports Ozempic and Rybelsus protocol tracking with injection reminders, titration calendars, weight logging, and Apple Health and Google Health Connect integration.

This article is for informational purposes only and does not constitute medical advice. Discuss all treatment decisions with your healthcare provider.

Ready to track your GLP-1?

  • Smart reminders so you never miss a dose
  • Track weight, photos, and progress over time
  • Medication level curves for 150+ compounds

Frequently Asked Questions

Is Ozempic available in India in 2026?

Yes. Ozempic is registered and available in India, primarily for T2DM management. It is available at major hospital pharmacies and select retail pharmacy chains in metro cities with a valid prescription.

How much does Ozempic cost in India?

Cost depends on dose, so check the MRP printed on the pack with your pharmacy. We could not verify a current official price list. According to press reports, Novo Nordisk cut Ozempic prices in India in 2026, and generic semaglutide from domestic manufacturers has been launching since March 2026.

Is Rybelsus (oral semaglutide) available in India?

Yes. Rybelsus is approved and available in India for type 2 diabetes management. It is a good option for patients who prefer oral administration over weekly injections. Check the MRP and tablet count on your box with your pharmacy.

When will generic GLP-1 medications be available in India?

According to press reports, the semaglutide patent in India expired in March 2026 and Indian manufacturers have since launched generic semaglutide. Ask your prescriber about Indian-manufactured alternatives to branded Novo Nordisk pricing.

Can I get a GLP-1 prescription through telehealth in India?

Yes. Platforms including Practo and mfine offer endocrinologist consultations online and can issue valid prescriptions. This makes GLP-1 access practical for patients outside major metro areas.

Regimen peptide and GLP-1 tracker app screenshot

Get the app

Track your GLP-1 protocol in Regimen.

Reminders that keep you on track, and built-in pattern detection that shows how your body responds.

Free to download. Free for your first compound.

Regimen app Today view with doses and estimated levels